Identification of nano-mechanical fingerprints as a biomarker for cancer treatment prognosis

Project Information

CancerFingerPrints

Grant agreement ID: 838414

DOI

10.3030/838414

Project closed

EC signature date 12 March 2019

Start date 1 May 2019

End date 31 October 2020

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 150 000,00

EU contribution

€ 150 000,00

Coordinated by

UNIVERSITY OF CYPRUS
Cyprus

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity

Author(s): Myrofora Panagi, Chrysovalantis Voutouri, Fotios Mpekris, Panagiotis Papageorgis, Margaret R Martin, John D Martin, Philippos Demetriou, Chryso Pierides, Christiana Polydorou, Andreas Stylianou, Maria Louca, Laura Koumas, Paul Costeas, Kazunori Kataoka, Horacio Cabral, Triantafyllos Stylianopoulos
Published in: Theranostics, Issue 10/4, 2020, Page(s) 1910-1922, ISSN 1838-7640
Publisher: Ivyspring International Publisher
DOI: 10.7150/thno.36936